Skandinaviska Enskilda Banken (SEB)
PTLA

Skandinaviska Enskilda Banken (SEB)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-60,509
Closed -$1.09M – 1157
2020
Q2 		$1.09M Buy
+60,509
New +$842K 0.01% 711

Skandinaviska Enskilda Banken (SEB)'s PTLA Position: Q3 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 60,509 shares — an estimated $1.09M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $1.09M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 60,509 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.09M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Portola Pharmaceuticals, Inc. position peaked at $1.09M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2020, filed 12 Nov 2020.